The image was taken inside a vaccination center located in the railway museum of Catalonia in Vilanova i La Geltru City, Spain. Persons receiving AstraZeneca’s Covid-19 vaccine rest at the follow-up area after vaccination. (Image: Getty Images) Medical staff giving flu vaccines to residents not participating in the community Covid-19 vaccination program established at the National Museum of Science and Technology of Leonardo Da Vinci in cooperation with the Leonardo Da Vinci Hospital in Milan, Italy. (Photo: EPA) Chairs in the post-vaccination monitoring room in the city of Naples, Italy, are placed at a guaranteed social distance. (Image: Getty Images) “Medical train” Akademik Fyodor Uglov in Kuytun village, Irkutsk region, Russia. The train is being used as a mobile diagnostic center, and staff on board are deploying Sputnik V vaccination to locals along the East Siberian Railway. (Photo: TASS) A Covid-19 vaccination clinic on the square of the SNCF station vaccination center in Nice City, France. (Photo: Shutterstock) The Robert Poirier Athletics Stadium in Rennes, Britany Province, France, has been transformed into the Pfizer / BioNTech Covid-19 vaccination center. (Image: Getty Images) Medical staff preparing to vaccinate at the Metropolitano Stadium in Madrid, Spain. (Photo: AP) Poland’s Wroclaw city prepares for a mass vaccination campaign at the city stadium. (Photo: Shutterstock) Aalborg Symphony Orchestra performs at an immunization center in Jutland, Denmark. (Photo: EPA) Residents sit in cars waiting for Covid-19 vaccinations at an immunization site at NRG Park complex, Houston City, Texas, USA. (Photo: AP) Cars move through traffic posts leading to the vaccination center inside Dodgers Stadium in Los Angeles, California, USA. To date, the state of nearly 40 million people has had nearly 19 million doses of Covid-19 vaccine, with nearly 6.9 million fully vaccinated. (Photo: AP) The line of vehicles waiting for the Covid-19 test at Dodger Stadium, Los Angeles City. The United States, the country most heavily affected by Covid-19, stressed that vaccination was the way to bring the country out of the pandemic. (Photo: AP) Photographed while waiting in line for AstraZeneca’s Covid-19 vaccination at the Olympic Stadium in Montreal, Canada. (Photo: AP)

The porter is sending the boxes of vaccines to Jumla (Nepal). Photo source: UNICEF The corona virus has spread to every continent, now infecting at least 128 million people worldwide. How widespread the epidemic was, devastating economies there. Many people in Africa, Asia and Latin America are waiting to be vaccinated. So far, nearly 600 million doses of the vaccine have been used around the world, but two-thirds of them are in just six countries. About 60% of Israelis have been vaccinated once, 50% of Britons have been vaccinated, and 1 out of 10 Germans get it. In Namibia, where a population of more than 2 million people, less than 1500 people are vaccinated. Aside from Namibia, no African country has received the vaccine. To prevent that, the COVAX project was born. WHO started COVAX a year ago, and the Vaccine Coalition (GAVI) and the Alliance for Epidemic Preparation Innovation (CEPI) are participating in nearly every country in the world. The goal is to have the 92 poorest members receive as many vaccines as the 98 richest members. It is expected that by the end of 2021, each country will receive the vaccine for 1/5 of the population. UNICEF wants vaccines to reach their destination, making them available to people regardless of race or wealth. So how can COVAX achieve its ambitious goals? Project 2 billion doses of vaccine to reach poor countries Mr. Benjamin Schreiber, COVAX Coordinator in Connecticut (USA) affirmed that the biggest challenge for countries is “preparing to vaccinate in a short time”. COVAX’s stated goal is to ship 2 billion doses of vaccine by the end of 2021, equivalent to 850 tons of vaccine / month and 1 billion syringes. Thousands of vaccine containers will reach the remotest corners of the earth by means of vehicles: Jeeps, boats, drones, and rickshaws. Countries receiving vaccine aid are diverse, some with developing economies, some with underdevelopment. Mr. Benjamin Schreiber, COVAX Coordinator in Connecticut (USA). Photo source: Katharina Poblotzki / Der Spiegel. Countries were required to send documents to UNICEF on how they plan to manage vaccine aid logistics: Which part of the population needs the vaccine most; Vaccine distribution plans from the airport to the rest of the country. On February 24, 2021, the first COVAX shipment landed in Ghana. By the end of March 2021, UNICEF had shipped 20 million doses of the vaccine to 47 countries. The strength of manufacturers The Indian Serum Institute (SII) is headquartered in Pune (West India), the world’s largest vaccine factory with 2.4 million doses of vaccine per day. SII is the creation of the vaccine that is being used to reach many parts of the world and its cost cannot be replicated right now. Of the more than 39 million doses of vaccine shipped by COVAX to date, 28 million have come from the Pune laboratories. India is a major supplier of COVAX. Currently, the country mainly produces vaccine AstraZeneca. But at the end of March 2021, the Indian government decided to stop the export of vaccines to a minimum when the number of new corona virus infections increased rapidly in this country. The New Delhi government’s decision to stockpile vaccines means COVAX will delay delivery of 90 million doses of vaccine to 63 receiving countries. There is currently no alternative manufacturing solution outside of India. The plane was carrying carton boxes containing COVID-19 vaccine at Mumbai airport in Maharashtra state (India) on 24 February 2021. Photo source: UNICEF / UN 0421823 / COVAX. Mr. Mounir Bouazar (head of the logistics division of COVAX in Copenhagen) has been preparing for 3-4 months for the first shipments of vaccines. By the end of 2020, Bouazar is certain that half a billion syringes will be distributed to four UNICEF warehouses in Copenhagen, Dubai, Panama and Shanghai. Now COVAX will deliver thousands of vaccines to their destination every day. But a pandemic makes it more difficult, with few or no flights due to limited travel. No flights to East Timor or the Pacific island nation have been requested by UNICEF. Vaccines and syringes moved to Yemen had to go to Nairobi, where Bouazar rented a small plane to carry vaccines and syringes. Bouazar hopes to ship more vaccines by mid-2021. There is an idea to make Bouazar’s work smoother right now: Suspend intellectual property rights to vaccines in a limited way during a pandemic. India and South Africa have filed requests to the World Trade Organization (WTO) to suspend the COVID-19 vaccine and drug patents, which are supported by 100 countries. Then other companies can also make vaccines. COVAX coordinator Benjamin Schreiber is deploying COVID-19 vaccine to the poorest and most isolated countries in the world. Connecting with him are 2 colleagues of UNICEF branches in Panama and Haiti – 2 countries with immunization delays. In Haiti, the vaccination team is ready, but problems are hampering vaccine shipments. Fuel in Haiti is quite expensive, roads are poor … Schreiber persistently connects with people in Haiti every day. Nguyen Thanh Hai ( (According to spiegel, April 24, 2021) )

The Royal Thailand Notice has published the country’s vaccine passport format form, with the official name of the “Covid-19 immunization certificate”, which contains the name, passport number and nationality of the person who received the vaccine. vaccinations. Only people who get vaccinated in Thailand or are certified by the World Health Organization can be issued with vaccine passports. Photo: Tan Hoa commune Vaccine passport issued by Thailand can only be used for 1 person and children under 7 years old must have parent’s signature on their passport. Only six senior health officials in Thailand are authorized to sign the vaccine passport. Thailand currently records more than 46,000 Covid-19 cases and the country is stepping up its national vaccination campaign. Thailand’s Ministry of Health is expected to let people book vaccinations through an application on the phone from May 1 to. Thailand is planning to purchase an additional 5 million to 10 million doses of Pfizer’s Covid-19 vaccine to meet the country’s need for immunization.

“This tuning is better for the current, unpredictable and ever-evolving threat of Covid-19. We continue to recommend that US citizens reconsider traveling abroad and postpone trips if possible, ”the ministry wrote in an email. In a media statement, the agency said the change does not “imply an assessment of the current health situation in a particular country”, but rather an advice for US citizens, in addition to information from the US Centers for Disease Control and Prevention (CDC). America warns people not to move to 80% of the countries of the world. Photo: Reuters. In addition to reflecting on travel health notices issued by the CDC, US State Department advisers are looking at logistical factors, such as travel restrictions for US citizens. If the passenger decides to go to the countries with a level 4 warning, the State Department recommends that they carefully read the information about the risks of arrival. The warning comes as the number of US passengers continues to increase and many countries around the world begin to open their borders to Americans. On April 19, Greece started to allow US citizens to re-enter if they have a negative test certificate for the virus or have been vaccinated. United Airlines has also announced new flights to Greece, Iceland and Croatia, starting in July. Earlier this month, the CDC said fully vaccinated people could move, and the risk this group poses is quite low. Even so, the agency said it still discourages movement as the number of new Covid-19 infections is still increasing in the US and globally. On its website, the agency recommends that residents postpone international trips until everyone is fully vaccinated. The agency warned: “Passengers who are fully vaccinated are less likely to become infected and spread Covid-19. However, international migration is still potentially risky and even fully immunized people are at risk of catching new virus strains and spreading them to the community ”.

CONTENT::::

1. Classification of the respondent mumps vaccine
2. Classification of the double mumps vaccine

1. Classification of the respondent mumps vaccine1.1. Defendant mumps vaccine classification concept

The mumps vaccine is the only vaccine that prevents mumps. It is usually a vaccine containing a live virus. The virus has been adapted and propagated in chicken embryonic cell culture. The preparation of the mumps vaccine classification is usually in the form of sterile, lyophilized powder. So need to prepare vaccines before injection.

The defendant mumps vaccine classification is indicated for vaccination in children over 12 months of age. It is not recommended for infants under 12 months of age, as the child’s body may still be retaining protective antibodies from the mother. This will interfere with the immune response, affecting the vaccine’s effectiveness.

Defendant mumps vaccine is not recommended for infants under 12 months (Image: Internet)

1.2. Side effects

The mumps vaccine classification the defendant may have side effects such as:

– Itching or stinging at the injection site.

– Fever.

Rash, redness of the skin, especially around the ears.

When does the status

Unusual fatigue or weakness.

– Have allergic reactions such as difficulty breathing, difficulty swallowing, itching of the feet or hands, swelling of the eyes or inside of the nose, …

Rare effects may include:

– Appears bruises on the skin.

– High fever.

Severe headache.

– Anger, bewildered.

Pain or swelling in the testicles and scrotum in men.

– Neck is stiff.

– Vomiting.

1.3. Note when using mumps vaccine

If you have a history of allergies, let your doctor know. Especially if you are hypersensitive to eggs. This is because live mumps vaccines are produced in chicken embryonic cell culture.

Studies in women show that the mumps vaccine classification poses minimal risk to the infant when used during lactation.

In people with weakened immune systems it may decrease the effectiveness of the vaccine or may increase the risk and severity of side effects.

2. Classification of the double mumps vaccine2.1. Common mumps vaccines

Currently, the mumps vaccine is used very rarely, replacing the dual vaccine. The double mumps vaccine is also known as the mumps vaccine. In addition to the mumps vaccine, the double mumps vaccine is also effective against a number of other infectious diseases. The most common types of mumps vaccine available today are MMR and MMRV.

In addition to the mumps vaccine, the double mumps vaccine is also effective in preventing a number of other infectious diseases (Photo: Internet)

– MMR vaccine protects the body against 3 diseases: measles, mumps and rubella.

– The MMRV vaccine protects the body against 4 diseases: measles, mumps, rubella and chickenpox.

These are very contagious diseases. They can be passed from person to person through coughing, sneezing or just by breathing.

2.2. The dose of mumps vaccine is double

The double mumps vaccine is usually in the “attenuated” form of each virus. That means they are the weakened life form of the virus in medical laboratories. The drug can be given to children from 12 months to 12 years. Ideally:

– The first dose when the child is from 12 to 15 months old.

– The second dose when the child is from 4 to 6 years old.

2.3. Side effects

Pain, redness, or rash where the shot was given.

– Fever.

Children may experience side effects such as fever after dual mumps vaccination (Image: Internet)

Swelling of glands in the cheeks or neck.

Allergic reactions such as hives, swelling of the face and throat, difficulty breathing, rapid heartbeat, dizziness or weakness may occur.

– More serious reactions may include convulsions due to high fever, unusual bleeding or bruising from low platelets, etc.

Reference source: https://www.rxlist.com/mumpsvax-drug.htm#warnings

AstraZeneca’s COVID-19 vaccine. Photo: AFP/TTXVN

According to the Ministry of Health, the man was injected with a vaccine produced at India’s Serum Institute. The patient has returned home and is in the process of recovering.

Earlier, Canada limited AstraZeneca’s vaccine use to people over the age of 55 due to concerns about the rare reaction. The above information is the latest challenge for vaccination in Canada.

In addition, Health Canada confirmed that it is in discussions with Johnson & Johnson about the possibility of a COVID-19 vaccine. The department has asked Johnson /Johnson for information on any cases of post-injection blood clots. The agency is also working with the U.S. Food and Drug Administration (FDA) and other international agencies on the issue.

Although Canada has licensed Johnson&Johnson’s vaccine, the vaccines ordered will not be shipped until the end of April. Canada is expected to get enough vaccines so that by the end of June, each citizen can get one shot. However, the rate of spread of the new variants of the SARS-CoV-2 virus is surpassing the progress of vaccination in the country.

The number of new cases in the last week has increased by 33%, while the number of new daily infections is at more than 8,100, equivalent to the peak of the second wave of outbreaks earlier this year. Canadian Prime Minister Justin Trudeau warned more dangerous new variations were spreading rapidly and threatened progress had been made.

According to statistics worldometers.info, Canada has a total of over 1 million infections and over 23,000 deaths from COVID-19.

* Meanwhile, Australia announced that it will send Trade Minister Dan Tehan to Europe on April 15 amid reports that it has ordered more than 3 million doses of AstraZeneca’s vaccine made in the European Union (EU) but has not received the goods.

Under the plan, Minister Tehan will have dialogues with his German, French and EU colleagues to discuss eu production and export limits on AstraZeneca’s vaccines.

Australia is one of the countries that succeeds in controlling the COVID-19 epidemic. Since the outbreak, the country has recorded nearly 30,000 cases. However, Australia is currently behind in its vaccination campaign. As of April 11, Australia had only vaccinated nearly 1.2 million people, despite a pledge by the end of March to vaccinate 4 million people.

The Australian government believes that the EU’s non-delivery of the vaccines it ordered by AstraZeneca was the cause of the delay in the vaccination program, but state authorities pointed out that the distribution of vaccines to health facilities also contributed to this situation.

Under pressure from public opinion, Australian Prime Minister Scott Morrison said he would convene a cabinet meeting twice a week with state and territory leaders until the issue was resolved and put the vaccination program back on track.

Australia intends to vaccinate the majority of the population with AstraZeneca’s vaccine, which has imports from Europe and domestic production, while waiting for supplies from Pfizer and Novavax. The Australian government recently admitted it may not meet its target for COVID-19 vaccination for all residents next October due to import delays and new concerns about vaccine side effects.

* In Ireland, Health Minister Stephen Donnelly said the country is considering extending the vaccination period between Pfizer/BioNTech’s two doses to more than 4 weeks to maintain the vaccination progress, amid concerns that other vaccines such as AstraZeneca and Johnson /Johnson are being restricted from use due to safety risks.

In Russia, President Vladimir Putin confirmed he had given two shots against COVID-19. Speaking on television, Mr Putin expressed hope people would do the same to take care of themselves and their loved ones.

On March 23, President Putin received his first shot of the COVID-19 vaccine.

The Kremlin did not specify the type of vaccine the Russian President was vaccinated against, but insisted it was among three Russian-developed vaccines including Sputnik V, EpiVacCorona and CoviVac. In the interview, Mr Putin said he had suffered minor side effects such as muscle pain after his first injection but did not have a fever.